Details of the Drug
General Information of Drug (ID: DMDQL24)
Drug Name |
4,5,6,7-Tetrahydro-1H-indazole-3-carboxylic acid
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
4,5,6,7-Tetrahydro-1H-indazole-3-carboxylic acid; 6076-13-7; 4,5,6,7-Tetrahydro-2H-indazole-3-carboxylic acid; 714255-28-4; CHEMBL338405; LWXNHFZBFJMHGU-UHFFFAOYSA-N; 2H-Indazole-3-carboxylicacid, 4,5,6,7-tetrahydro-; 1H-Indazole-3-carboxylic acid, 4,5,6,7-tetrahydro-; 2H-Indazole-3-carboxylic acid, 4,5,6,7-tetrahydro-; 1H-4,5,6,7-tetrahydroindazole-3-carboxylic acid; MLS000074645; AC1LDJ0A; ChemDiv2_003320; Oprea1_089683; AC1Q748E; SCHEMBL1808017; AC1Q72Q0; CTK2H6469; DTXSID00349466; MolPort-000-767-792; MolPort-000-149-162
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 166.18 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 1.3 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 1 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 3 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||